Health Care Equipment & Supplies · NYSE
ABTAbbott Laboratories
- Last close
- $108.52 +1.2%
- 52-week range
- $81.97 to $132.03
- Market cap
- $188B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Below its 10-year median on 3 of 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 40.4x
- Earnings yield
- 2.5%
- Price / sales
- 3.9x
- Price / book
- 3.7x
- Price / operating cash flow
- 21.2x
- EV / EBITDA
- 26.1x
- EV / sales
- 4.5x
- Free cash flow yield
- 3.6%
Profitability
- Gross margin
- 56.9%
- Operating margin
- 13.8%
- Net margin
- 9.7%
- Return on equity
- 9.2%
- Return on capital
- 5.8%
Growth per year
- Revenue, 3 years
- +0.5%
- Revenue, 5 years
- +5.1%
- Revenue, 9 years
- +8.7%
- EPS, 3 years
- -1.6%
Balance sheet
- Cash and investments
- $4.30B
- Total debt
- $31.2B
- Net cash
- -$26.9B
- Debt / equity
- 0.61x
- Current ratio
- 1.45x
Shares and dividend
- Shares outstanding
- 1.73B
- Share count, 5 years
- -2.1%
- Beta, 1 year
- 0.07
- Dividend yield
- 2.3%
- Dividend per share, TTM
- $2.52
- Payout ratio
- 92.0%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
US went from 42% to 39% of revenue in 3 years
Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.
| Region | Revenue | Share | vs FY24 |
|---|---|---|---|
| US | $17.1B | 38.6% | +5% |
| All Other Countries | $16.0B | 36.0% | +8% |
| DE | $2.76B | 6.2% | +9% |
| CN | $1.91B | 4.3% | -10% |
| CH | $1.87B | 4.2% | +7% |
| IN | $1.87B | 4.2% | +3% |
| Other | $2.81B | 6.4% | +7% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| BSX Boston Scientific Corp | $64.3B | +9% | 18.7% | 18.8x | 3.1x | 22nd percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- CEO
- Miles D. White
- Employees
- 73,000 (as of 2015)
- Founded
- 1888
- Headquarters
- Abbott Park, IL
- Fiscal year ends
- December
- Website
- abbott.com
What it does
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about ABT.